72
Views
0
CrossRef citations to date
0
Altmetric
Original article

Cataract Phacoemulsification in People with Dementia: Characterization and Outcomes

, , , , &
Received 21 Feb 2023, Accepted 31 Oct 2023, Published online: 16 Nov 2023

References

  • Steinmetz JD, Bourne RRA, Briant PS. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health. 2021;9(2):e144–e160. doi:10.1016/S2214-109X(20)30489-7.
  • Jaul E, Barron J. Age-related diseases and clinical and public health implications for the 85 years old and over population. Front Public Health. 2017;5:335. doi:10.3389/fpubh.2017.00335.
  • Olfson M, Stroup TS, Huang C, et al. Age and Incidence of Dementia Diagnosis. J Gen Intern Med. 2021;36(7):2167–2169. doi:10.1007/s11606-020-05895-y.
  • Ma L-Z, Zhang Y-R, Li Y-Z, et al. Cataract, cataract surgery, and risk of incident dementia: a prospective cohort study of 300,823 participants. Biol Psychiatry. 2022;93(9):810–819. doi:10.1016/j.biopsych.2022.06.005.
  • Shang X, Zhu Z, Wang W, et al. The association between vision impairment and incidence of dementia and cognitive impairment: a systematic review and meta-analysis. Ophthalmology. 2021;128(8):1135–1149. doi:10.1016/j.ophtha.2020.12.029.
  • Tran EM, Stefanick ML, Henderson VW, et al. Association of visual impairment with risk of incident dementia in a women’s health initiative population. JAMA Ophthalmol. 2020;138(6):624–633. doi:10.1001/jamaophthalmol.2020.0959.
  • Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet. 2020;396(10248):413–446. doi:10.1016/S0140-6736(20)30367-6.
  • Kuzma E, Littlejohns TJ, Khawaja AP, et al. Visual impairment, eye diseases, and dementia risk: a systematic review and meta-analysis. J Alzheimers Dis. 2021;83(3):1073–1087. doi:10.3233/JAD-210250.
  • Asbell PA, Dualan I, Mindel J, et al. Age-related cataract. Lancet. 2005;365(9459):599–609. doi:10.1016/S0140-6736(05)70803-5.
  • Jefferis JM, Mosimann UP, Clarke MP. Cataract and cognitive impairment: a review of the literature. Br J Ophthalmol. 2011;95(1):17–23. doi:10.1136/bjo.2009.165902.
  • Kessel L, Andresen J, Erngaard D, et al. Indication for cataract surgery. Do we have evidence of who will benefit from surgery? A systematic review and meta-analysis. Acta Ophthalmol. 2016;94(1):10–20. doi:10.1111/aos.12758.
  • Jefferis JM, Clarke MP, Taylor JP, Brittain KR. Challenges for the cataract surgeon treating people with dementia: a qualitative study exploring anesthetic choices. Clin Ophthalmol. 2014;8:1993–1999. doi:10.2147/OPTH.S69388.
  • Kumar CM, Gopal L, Seet E. Choosing anesthesia options for cataract surgery in patients with dementia. J Anaesthesiol Clin Pharmacol. 2019;35(1):81–84. doi:10.4103/joacp.JOACP_22_18.
  • Chen L, Au E, Saripella A, et al. Postoperative outcomes in older surgical patients with preoperative cognitive impairment: a systematic review and meta-analysis. J Clin Anesth. 2022;80:110883. doi:10.1016/j.jclinane.2022.110883.
  • Pershing S, Henderson VW, Bundorf MK, et al. Differences in cataract surgery rates based on dementia status. J Alzheimers Dis. 2019;69(2):423–432. doi:10.3233/JAD-181292.
  • Lee CS, Gibbons LE, Lee AY, et al. Association between cataract extraction and development of dementia. JAMA Intern Med. 2022;182(2):134–141. doi:10.1001/jamainternmed.2021.6990.
  • Pershing S, Henderson VW, Goldstein MK, et al. Cataract surgery complexity and surgical complication rates among medicare beneficiaries with and without dementia. Am J Ophthalmol. 2021;221:27–38. doi:10.1016/j.ajo.2020.08.025.
  • Stein JD, Lum F, Lee PP, et al. Use of health care claims data to study patients with ophthalmologic conditions. Ophthalmology. 2014;121(5):1134–1141. doi:10.1016/j.ophtha.2013.11.038.
  • Health Insurance Portability and Accountability Act. Pub. L. No. 104-191, § 264, 110 Stat. 1936. Unites States 2006.
  • World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi:10.1001/jama.2013.281053.
  • Miller DC, Patnaik JL, Palestine AG, et al. Cataract surgery outcomes in human immunodeficiency virus positive patients at a tertiary care academic medical center in the United States. Ophthalmic Epidemiol. 2021;28(5):400–407. doi:10.1080/09286586.2020.1866021.
  • R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria. 2022.
  • Højsgaard S, Halekoh U, Yan J. The R package geepack for generalized estimating equations. J Stat Softw. 2006;15(2):1–11. doi:10.18637/jss.v015.i02.
  • Anthrayose CV, Shashidhar S. Studies on protein and taurine in normal, senile and diabetic cataractous human lenses. Indian J Physiol Pharmacol. 2004;48:357–360.
  • Arai H, Kobayashi K, Ichimiya Y, et al. Free amino acids in post-mortem cerebral cortices from patients with Alzheimer-type dementia. Neurosci res. 1985;2(6):486–490. doi:10.1016/0168-0102(85)90020-3.
  • Aquilani R, Costa A, Maestri R, et al. Mini nutritional assessment May identify a dual pattern of perturbed plasma amino acids in patients with Alzheimer’s disease: a window to metabolic and physical rehabilitation? Nutrients. 2020;12(6):1845. doi:10.3390/nu12061845.
  • Chouraki V, Preis SR, Yang Q, et al. Association of amine biomarkers with incident dementia and Alzheimer’s disease in the Framingham study. Alzheimers Dement. 2017;13(12):1327–1336. doi:10.1016/j.jalz.2017.04.009.
  • Oh SJ, Lee HJ, Jeong YJ, et al. Evaluation of the neuroprotective effect of taurine in Alzheimer’s disease using functional molecular imaging. Sci Rep. 2020;10(1):15551. doi:10.1038/s41598-020-72755-4.
  • Jang H, Lee S, Choi SL, et al. Taurine directly binds to Oligomeric Amyloid-beta and recovers cognitive deficits in Alzheimer model mice. Adv Exp Med Biol. 2017;975(Pt 1):233–241.
  • Rafiee Z, Garcia-Serrano AM, Duarte JMN. Taurine supplementation as a neuroprotective strategy upon brain dysfunction in metabolic syndrome and diabetes. Nutrients. 2022;14(6):1292. doi:10.3390/nu14061292.
  • Wesolosky JD, Rudnisky CJ. Relationship between cataract severity and socioeconomic status. Can J Ophthalmol. 2013;48(6):471–477. doi:10.1016/j.jcjo.2013.07.001.
  • Storey P, Munoz B, Friedman D, West S. Racial differences in lens opacity incidence and progression: the Salisbury Eye Evaluation (SEE) study. Invest Ophthalmol Vis Sci. 2013;54(4):3010–3018. doi:10.1167/iovs.12-11412.
  • Mahr MA, Hodge DO, Erie JC. Racial/Ethnic differences in rates of complex cataract surgery among United States medicare beneficiaries. J Cataract Refract Surg. 2018;44(2):140–143. doi:10.1016/j.jcrs.2017.10.049.
  • Nagarajan N, Assi L, Varadaraj V, et al. Vision impairment and cognitive decline among older adults: a systematic review. BMJ Open. 2022;12(1):e047929. doi:10.1136/bmjopen-2020-047929.
  • Maharani A, Dawes P, Nazroo J et al . Cataract surgery and age-related cognitive decline: a 13-year follow-up of the English longitudinal study of ageing. PLoS One. 2018;13(10):e0204833. doi:10.1371/journal.pone.0204833.
  • Corzo K, Farabi B, Lahoti L. The link between frontotemporal dementia and autoimmunity: a case presentation and literature review. Cureus. 2022;14(4):e24617. doi:10.7759/cureus.24617.
  • Dove A, Marseglia A, Shang Y, et al. Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression. Alzheimers Dement. 2022;17(S10). doi:10.1002/alz.050473.
  • Ott A, Stolk RP, van Harskamp F, et al. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology. 1999;53(9):1937–1942. doi:10.1212/WNL.53.9.1937.
  • Ortiz GG, Huerta M, Gonzalez-Usigli HA, et al. Cognitive disorder and dementia in type 2 diabetes mellitus. World J Diabetes. 2022;13(4):319–337. doi:10.4239/wjd.v13.i4.319.
  • Kiziltoprak H, Tekin K, Inanc M, Goker YS. Cataract in diabetes mellitus. World J Diabetes. 2019;10(3):140–153. doi:10.4239/wjd.v10.i3.140.
  • Hou CH, Pu C. Medication adherence in patients with glaucoma and disability. JAMA Ophthalmol. 2021;139(12):1292–1298. doi:10.1001/jamaophthalmol.2021.4415.
  • Kessel L, Tendal B, Jorgensen KJ, et al. Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. Ophthalmology. 2014;121(10):1915–1924. doi:10.1016/j.ophtha.2014.04.035.
  • Arlt S, Lindner R, Rosler A, von Renteln-Kruse W. Adherence to medication in patients with dementia: predictors and strategies for improvement. Drugs Aging. 2008;25(12):1033–1047. doi:10.2165/0002512-200825120-00005.
  • Stagg BC, Choi H, Woodward MA, Ehrlich JR. Association of social support network size with receipt of cataract surgery in older adults. JAMA Ophthalmol. 2018;136(4):423–427. doi:10.1001/jamaophthalmol.2018.0244.
  • Shorstein NH, Myers WG. Drop-free approaches for cataract surgery. Curr Opin Ophthalmol. 2020;31(1):67–73. doi:10.1097/ICU.0000000000000625.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.